Daily aspirin in adults with type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This early-stage study tests how a daily aspirin tablet behaves in the body and how it affects blood/clotting markers in people with type 2 diabetes. It may help researchers understand whether this form of aspirin could be useful, especially if you’re not currently taking aspirin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older
- Have type 2 diabetes (you meet it by medication use or specific blood test results like A1c, fasting glucose, or glucose test results)
- Have not taken aspirin regularly: no chronic aspirin in the last 3 months and no aspirin in the last 2 weeks
- Be able and willing to come to all study visits (including a run-in period and the main study)
- Not have a reason/need to take aspirin for heart or blood-vessel disease (no known atherosclerotic disease or related history)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental daily tablet for adults with type 2 diabetes who are not currently on any diabetes medication. It aims to see if the tablet can safely lower blood sugar levels over time.
This trial tests whether an SGLT2 inhibitor pill can help people who have atrial fibrillation (an irregular heartbeat) and type 2 diabetes. You may be eligible if you’re in the right age range, on diabetes pills only, and meet specific heart and lab criteria.
This study looks at how platelets (the cells that help your blood clot) change in people with type 2 diabetes. It may help doctors understand diabetes better and find new ways to manage it.
This trial tests whether taking aspirin can help people who have early signs of coronary artery disease (buildup in heart arteries) but have never had a heart attack or stroke. The goal is to see if aspirin prevents future heart problems in these patients.
This study tests whether a low dose of aspirin can protect the kidneys in people with early diabetic kidney disease. It aims to see if aspirin slows down kidney damage without causing serious side effects.
This trial tests whether taking cilostazol and aspirin together can help prevent heart attacks, strokes, and other cardiovascular events in people with type 2 diabetes who have early signs of artery disease or metabolic syndrome. It aims to see if this combination is more effective than aspirin alone.
Hear when a new Platelet Aggregation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.